Furthermore, 1132 breast (grey dotted box) and 420 ovarian cancer (black dotted box) patients’ tumors had significantly higher expression of PARP-1 in both cancers compared to all normal tissues except bone marrow and spleen (one-way ANOVA; p-value < 0.05; Figure 1). This evidence concerns the gene PARP1 and ovarian carcinoma.